Blog
RSS FeedPosted by Michael Wonder on 20 Nov 2019
Life saving therapy denied to dying cop
20 November 2019 - Doctors at Sydney’s Royal Prince Alfred Hospital are refusing to treat a terminally ill cancer patient ...
Posted by Michael Wonder on 20 Nov 2019
Medexus granted priority review status for Gliolan by Health Canada
19 November 2019 - Medexus Pharmaceuticals today announced that Health Canada has granted priority review status for the new drug ...
Posted by Michael Wonder on 20 Nov 2019
Genmab announces European marketing authorization for Darzalex (daratumumab) in combination with lenalidomide and dexamethasone in frontline multiple myeloma
19 November 2019 - Approval based on data from Phase III MAIA study. ...
Posted by Michael Wonder on 19 Nov 2019
Game changing cancer medicines now within reach for 2,200 Australians
20 November 2019 - Australians living with non-small cell lung cancer and early stage acute lymphoblastic leukaemia will be able to ...
Posted by Michael Wonder on 19 Nov 2019
Lung cancer and leukaemia treatments to be added to PBS
19 November 2019 - “Game changing” drugs for types of lung cancer and leukaemia will be added to the Pharmaceutical Benefits ...
Posted by Michael Wonder on 17 Nov 2019
CHMP recommends EU approval of Roche’s Kadcyla for the adjuvant treatment of people with HER2-positive early breast cancer with residual invasive disease after neo-adjuvant treatment
15 November 2019 - Kadcyla cut the risk of disease recurrence or death by half compared to Herceptin in the adjuvant ...
Posted by Michael Wonder on 17 Nov 2019
CHMP recommends conditional EU approval of Roche’s Polivy for people with previously treated aggressive lymphoma
15 November 2019 - First-in-class antibody-drug conjugate that specifically targets CD79b, a protein expressed in the majority of B-cells. ...
Posted by Michael Wonder on 14 Nov 2019
FDA approves therapy to treat patients with relapsed and refractory mantle cell lymphoma supported by clinical trial results showing high response rate of tumour shrinkage
14 November 2019 - Today, the U.S. FDA granted accelerated approval to Brukinsa (zanubrutinib) capsules for the treatment of adult patients ...
Posted by Michael Wonder on 13 Nov 2019
Clovis Oncology announces reimbursement for Rubraca (rucaparib) tablets for women with relapsed ovarian cancer in Italy
13 November 2019 - Rucaparib now reimbursed in several countries in Europe with additional countries to follow in 2020. ...
Posted by Michael Wonder on 13 Nov 2019
FDA’s Project Orbis may expand to Singapore and Switzerland
12 November 2019 - The US FDA may expand a pilot project that allows for simultaneous drug approval decisions from ...
Posted by Michael Wonder on 13 Nov 2019
Viracta receives fast track designation for nanatinostat combination for the treatment of EBV-associated lymphomas
12 November 2019 - Viracta Therapeutic, announced today that the U.S. FDA has granted fast track designation for nanatinostat in ...
Posted by Michael Wonder on 13 Nov 2019
Exelixis’ partner Ipsen announces Health Canada’s approval of Cabometyx (cabozantinib) tablets for the treatment of patients with previously treated advanced hepatocellular carcinoma
12 November 2019 - Approval based on statistically significant and clinically meaningful overall survival benefit demonstrated in the CELESTIAL phase 3 ...
Posted by Michael Wonder on 12 Nov 2019
Health economic assessment of Tecentriq for triple negative breast cancer
8 November 2019 - TLV has produced a health economic knowledge base for the county council for the drug Tecentriq (atezolizumab). ...
Posted by Michael Wonder on 12 Nov 2019
'Incredibly upsetting': breast cancer patients dealing with shortage of common drug treatment
12 November 2019 - When Tricia Smith tried to fill her prescription for tamoxifen two weeks ago, she was shocked ...
Posted by Michael Wonder on 12 Nov 2019
Lung cancer ALK+NSCLC genetic mutation screening could save lives - doctors
12 November 2019 - Lives are being needlessly cut short because there's no universal testing for a type of lung ...